Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2004-06-07
2009-10-13
Kosar, Andrew D (Department: 1654)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
Reexamination Certificate
active
07601731
ABSTRACT:
The present invention provides antimicrobial solutions that comprise at least one alcohol, at least one antimicrobial agent and at least one chelator and/or anticoagulant. Also provided are methods for rapidly reducing a microbe or a virus from surfaces including surfaces of indwelling medical devices and organic surfaces such as skin and sutures, and inorganic surfaces such as hospital equipment, pipelines etc.
REFERENCES:
patent: 4213979 (1980-07-01), Levine
patent: 4233263 (1980-11-01), Schaeffer
patent: 4349029 (1982-09-01), Mott
patent: 4592920 (1986-06-01), Murtfeldt
patent: 4863445 (1989-09-01), Mayhan et al.
patent: 5286479 (1994-02-01), Garlich et al.
patent: 5310524 (1994-05-01), Campbell et al.
patent: 5344652 (1994-09-01), Hall, II et al.
patent: 5362754 (1994-11-01), Raad et al.
patent: 5589507 (1996-12-01), Hall, II et al.
patent: 5688516 (1997-11-01), Raad et al.
patent: 5820607 (1998-10-01), Tcholakain et al.
patent: 5840343 (1998-11-01), Hall, II et al.
patent: 5871692 (1999-02-01), Haire et al.
patent: 5872104 (1999-02-01), Vermeulen et al.
patent: 5891422 (1999-04-01), Pan et al.
patent: 6068972 (2000-05-01), Levy
patent: 6150405 (2000-11-01), Proctor
patent: 6165484 (2000-12-01), Raad et al.
patent: 6187768 (2001-02-01), Wele et al.
patent: 6261457 (2001-07-01), Wenthold et al.
patent: 6267979 (2001-07-01), Raad et al.
patent: 6350251 (2002-02-01), Prosl et al.
patent: 6361524 (2002-03-01), Odell et al.
patent: 6368317 (2002-04-01), Chang
patent: 6428799 (2002-08-01), Cen et al.
patent: 6448006 (2002-09-01), Levy
patent: 6503539 (2003-01-01), Gestrelius et al.
patent: 6509319 (2003-01-01), Raad et al.
patent: 6559116 (2003-05-01), Godfroid et al.
patent: 6585934 (2003-07-01), Oberleitner et al.
patent: 6592564 (2003-07-01), Finch et al.
patent: 6679870 (2004-01-01), Finch et al.
patent: 6685694 (2004-02-01), Finch et al.
patent: 2002/0007175 (2002-01-01), Chang
patent: 2002/0010438 (2002-01-01), Finch et al.
patent: 2002/0052404 (2002-05-01), Hunter et al.
patent: 2002/0087156 (2002-07-01), Maguire et al.
patent: 2002/0133072 (2002-09-01), Wang et al.
patent: 2003/0007939 (2003-01-01), Murad
patent: 2003/0032605 (2003-02-01), Raad et al.
patent: 2003/0065292 (2003-04-01), Darouiche et al.
patent: 2003/0099718 (2003-05-01), Burrell et al.
patent: 0285382 (1987-04-01), None
patent: 0348947 (1990-01-01), None
patent: 1245247 (2002-10-01), None
patent: WO 94/10838 (1994-05-01), None
patent: WO 95/05203 (1995-02-01), None
patent: WO 95/32625 (1995-12-01), None
patent: WO 9713495 (1997-04-01), None
patent: WO 97/18707 (1997-05-01), None
patent: WO 9730685 (1997-08-01), None
patent: WO 99/17791 (1999-04-01), None
patent: WO 00/01238 (2000-01-01), None
patent: WO 00/07574 (2000-02-01), None
patent: WO 01/54661 (2001-08-01), None
patent: WO 02/45611 (2002-06-01), None
S.L. Werlin, et al. J. Parent. Enteral Nutr. (1995) 19(5), pp. 416-418.
A. Aydemir “Why 70% EtOH for cleaning?” internet document <http://www.bio.net/bionet/mm/methods/1995-June/029902.html> Jun. 19, 1995, 2 pages; accessed Aug. 25, 2006.
D.A. Johnson et al. Clin. Nutr. (1992) 11(2), pp. 97-100.
I. Raad et al. Antimicrob. Agent Chemother. (2007) 51(1), pp. 78-83.
G. McDonnell and D. Russell. Clin. Microbiol. Rev. (1999) 12(1) pp. 147-179.
L.W. Bush et al. J. Clin. Microbiol. (1986) 24(3), pp. 343-348.
C.H. Sissons et al. Arch. Oral Biol. (1996) 41(1), pp. 27-34.
N. Kurita and S. Koike, Argic. Biol. Chem. (1983) 47(1), pp. 67-75.
“Biofilm: disinfecting biofilms using hydrogen peroxide/silver based biocide,” Accepta: Leading eChemical Procurement, http://accepta.com, 2004.
“Removal of residual microbicide from sterilised medical devices—using a neutralising sol. comprising, e.g. ascorbic acid or an enzyme,” Dialog File, Derwent WPI, Thompson Derwent, 2004.
“The breakthrough technology behind STERRAD sterilization systems,” Advanced Sterilization Products, Johnson & Johnson Company, http://www.sterrad.com.
Chatzinikolaou et al., “Minocycline and Edta (M-EDTA) as a flush solution for implantable ports (IP) used in pediatric cancer patients,” Shea Merck Healthcare Epidemiology Search Abstracts, 2002.
Desautels et al., “Maintenance of sterility in urinary drainage bags,”Surg. Gynecol. Obstet., 154(6):838-840, 1982.
Johnston et al., “Ethanol flush for the prevention of catheter occlusion,”Clinical Nutrition, 11:97-100. 1992.
Kuhn et al., “Antifungal susceptibility of Candida biofilms: unique efficacy of amphotericin B lipid formulations and echinocandins,”Antimicrobial Agents and Chemotherapy, 46(6):1773-1780, 2002.
Lavallee et al., “Catheter cleaning for re-use in intermittent catherization: new light on an old problem,”SCI Nurs., 12(1):10-12, 1995.
Leon et al., “Antiseptic chamber-containing hub reduces central venous catheter-related infection: a prospective, randomized study,”Clinical Investigations, 31(5):1318-1324, 2003.
Ma et al., “Safety issue of re-sterilization of polyurethane electrophysiology catheters: a cytotoxicity study,”J. Biomater. Sci. Polym. Ed., 14(3):213-226, 2003.
Pennington et al., “Ethanol lock in the management of catheter occlusion,”Journal of Parenteral and Enteral Nutrition, 11(5):507-508, 1987.
Samuels and Fisher, “The use of hydrogen peroxide in catheter drainage units,”AUAA J., 3(3):5-9, 1983.
Schaeffer et al., “Bactericidal effect of hydrogen peroxide on urinary tract pathogens,”Applied and Environmental Microbiology, 40(2):337-340, 1980.
Schaeffer, “Hydrogen peroxide warrants careful consideration for control of catheter-associated bacteriuria,”Am J. Infect. Control, 10(4):158-160, 1982.
Shabino et al., “Home cleaning-disinfection procedure for tracheal suction catheters,”Pediatr. Infect. Dis., 5(1):54-58, 1986.
Shah et al., “Antimicrobial activity of a novel catheter lock solution,”Antimicrob. Agents Chemother., 46(6):1674-1679, 2002.
Sheretz and Bleyer, Invention Disclosure, dated Oct. 8, 1998.
Sheretz et al., “In vitro efficacy of minocyline (M)/EDTA (MEDTA) as a catheter lock solution,” Shea Merck Healthcare Epidemiology Search Abstracts, 2002.
Sweet et al., “Evaluation of H2O2 prophylaxis of bacteriuria in patients with long-term indwelling Foley catheters: a randomized controlled study,”Infect. Control, 6(7):263-266, 1985.
Thompson et al., “Catheter-associated bacteriuria. Failure to reduce attack rates using periodic instillations of a disinfectant into urinary drainage systems,”JAMA, 251(6):747-751, 1984.
Washington, “Instillation of 3% hydrogen peroxide or distilled vinegar in urethral catheter drainage bag to decrease catheter-associated bacteriuria,”Biol. Res. Nurs., 3(2):78-87, 2001.
Heinzel, “The phenomena of resistance to disinfectants and preservatives,” InIndustrial biocides, Payne (ed.), pp. 52, 56-58, and 64-66, 1988.
Lehmann, “Synergisms in disinfectant formulations,” InIndustrial biocides, Payne (ed.), pp. 78-79 and 89, 1988.
Board of Regents the University of Texas System
Fulbright & Jaworski LLP
Kosar Andrew D
LandOfFree
Antimicrobial flush solutions does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antimicrobial flush solutions, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antimicrobial flush solutions will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4105062